Ashwagandha

<h3> Absolute Contraindications of Ashwagandha </h3> <h4> Pregnancy (avoid during pregnancy) [Pregnant or planning to become pregnant]</h4> <ul> <li> 🤰</li> <li> Recommendation: Do not take ashwagandha while pregnant - stop supplements if you discover pregnancy and discuss with your clinician.</li> <li> Reasoning: Human pregnancy data are limited and historical/animal reports raised concerns about effects on reproductive tissues; major agencies advise avoidance until safety is proven in controlled human studies.</li> <li> Scientific_Study_Title: A Systematic and Ethnobotanical Review of Ashwagandha's (Withania Somnifera) Teratogenic and Abortifacient Potentials.</li> <li> Scientific_Study_Authors: Mark J Tallon, Igor Koturbash, Jason L Blum.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/40887707/</li> <li> Scientific_Study_Excerpt: <p>This recent systematic review examined historical, animal and human data on reproductive and developmental safety. The authors found that while traditional reports mention abortifacient uses and some animal data exist, the overall human evidence is sparse and inconclusive; they emphasise the lack of high-quality human pregnancy data and recommend a cautious approach until more rigorous studies are available. (Paraphrased summary of findings.)</p> </li> </ul> <h4> Breastfeeding / Lactation [Nursing parent]</h4> <ul> <li> 🍼</li> <li> Recommendation: Avoid ashwagandha while breastfeeding unless a clinician specifically advises otherwise; prefer proven safe options for lactation support.</li> <li> Reasoning: There are no robust human lactation studies; active constituents may pass into breastmilk or affect infant physiology and long-term safety is untested.</li> <li> Scientific_Study_Title: Ashwagandha: Usefulness and Safety (NCCIH summary).</li> <li> Scientific_Study_Authors: National Center for Complementary and Integrative Health (NCCIH) (organizational author).</li> <li> Scientific_Study_Link: https://www.nccih.nih.gov/health/ashwagandha</li> <li> Scientific_Study_Excerpt: <p>NCCIH states that ashwagandha should be avoided during pregnancy and should not be used while breastfeeding due to insufficient safety data; short-term safety data exist for adults but lactation-specific studies are lacking, so standard guidance is to avoid use during breastfeeding. (Paraphrase of NCCIH guidance.)</p> </li> </ul> <h4> Known or suspected liver disease / prior herb-induced liver injury [Existing liver problems]</h4> <ul> <li> ⚠️🍃</li> <li> Recommendation: Do not take ashwagandha if you have active liver disease, unexplained abnormal liver tests, or a prior supplement-related liver injury; consult hepatology before any herbal supplement.</li> <li> Reasoning: Multiple case reports and case series document cholestatic or mixed pattern liver injury temporally linked to ashwagandha supplements; some required hospitalization though most recovered after stopping the herb.</li> <li> Scientific_Study_Title: Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.</li> <li> Scientific_Study_Authors: Helgi K Björnsson, Einar S Björnsson, Bharathi Avula, Ikhlas A Khan, Jon G Jonasson, Marwan Ghabril, Paul H Hayashi, Victor Navarro.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31991029/</li> <li> Scientific_Study_Excerpt: <p>The case series describes five patients who developed cholestatic or mixed liver injury 2-12 weeks after starting ashwagandha products; symptoms included jaundice, pruritus and nausea. Investigations excluded other common causes, and most patients improved after stopping the supplement. The authors conclude a hepatotoxic potential for some ashwagandha formulations. (Paraphrase of abstract details.)</p> </li> </ul> <h4> On systemic immunosuppressant therapy or with active autoimmune disease requiring immunosuppression [People on drugs that deliberately lower immunity]</h4> <ul> <li> 🧬🛑</li> <li> Recommendation: Avoid using ashwagandha while on immunosuppressive drugs (e.g., post-transplant regimens, high-dose steroids, biologic immunosuppressants) unless supervised by the treating specialist.</li> <li> Reasoning: Clinical studies show ashwagandha can enhance multiple immune markers; this immunostimulatory effect could reduce effectiveness of immunosuppressants or worsen autoimmune activity in susceptible patients.</li> <li> Scientific_Study_Title: Immunomodulatory Effect of Withania somnifera (Ashwagandha) Extract - A Randomized, Double-Blind, Placebo Controlled Trial with an Open Label Extension on Healthy Participants.</li> <li> Scientific_Study_Authors: Ajit Tharakan, Himanshu Shukla, Irin Rosanna Benny, Matthan Tharakan, Lekha George, Santhosh Koshy.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34441940/</li> <li> Scientific_Study_Excerpt: <p>In a randomized placebo-controlled trial, subjects receiving ashwagandha (60 mg extract) showed significant increases in multiple immunoglobulin classes, cytokines (IFN-γ, IL-4) and counts/activation markers of T, B and NK cells versus placebo; the investigators concluded the extract modulated innate and adaptive immunity. This supports concern about using immune-stimulating botanicals while on immunosuppressive therapy. (Paraphrase.)</p> </li> </ul> <h4> Uncontrolled or known thyroid hyperfunction (active hyperthyroidism) [People with high thyroid activity]</h4> <ul> <li> 🩺⚖️</li> <li> Recommendation: Do not self-start ashwagandha if you have active hyperthyroidism; discuss with your endocrinologist because it may raise thyroid hormone levels or alter medication needs.</li> <li> Reasoning: Clinical trials demonstrate ashwagandha can increase circulating T3/T4 and reduce TSH in some people; in hyperthyroid patients this could worsen thyrotoxic symptoms or complicate drug titration.</li> <li> Scientific_Study_Title: Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial.</li> <li> Scientific_Study_Authors: Ashok Kumar Sharma, Indraneel Basu, Siddarth Singh.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/28829155/</li> <li> Scientific_Study_Excerpt: <p>In an 8-week randomized trial of subclinical hypothyroid patients, ashwagandha (600 mg/day) produced significant increases in T3 and T4 and decreased TSH versus placebo. While the trial was in hypothyroid subjects, the clear thyroid-modulating effect indicates a potential to alter thyroid status and medication needs. (Paraphrase of trial results.)</p> </li> </ul> <h3> Relative Contraindications of Ashwagandha </h3> <h4> Diabetes or using blood-glucose lowering medications [People with diabetes on medication]</h4> <ul> <li> 🍬⬇️</li> <li> Recommendation: If you have diabetes and choose to use ashwagandha, monitor blood glucose closely and coordinate with your clinician - medication dose adjustments may be needed.</li> <li> Reasoning: Ashwagandha shows hypoglycaemic activity in animal and human studies (improved insulin sensitivity and lower fasting glucose); combined with diabetic drugs it can increase hypoglycaemia risk.</li> <li> Scientific_Study_Title: Withania somnifera (Indian ginseng) in diabetes mellitus: A systematic review and meta-analysis of scientific evidence from experimental research to clinical application.</li> <li> Scientific_Study_Authors: Tiwari et al. (systematic review authors listed in paper).</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31975514/</li> <li> Scientific_Study_Excerpt: <p>Systematic review data indicate that W. somnifera improves blood glucose and HbA1c in animal models and limited human trials, and restores altered metabolic parameters. The authors note potential anti-diabetic effects and call for careful monitoring if used with antidiabetic therapy. (Paraphrase.)</p> </li> </ul> <h4> Concurrent use of sedatives / benzodiazepines / hypnotics [People taking sedating medicines]</h4> <ul> <li> 😴🛑</li> <li> Recommendation: Use caution - avoid combining without medical advice. If combined, expect additive drowsiness and possibly reduced alertness; do not drive or operate heavy machinery until you know the combined effect.</li> <li> Reasoning: Ashwagandha contains constituents that act via GABAergic pathways and in animal studies potentiated sedative effects; additive CNS depression with prescription sedatives is a reasonable clinical concern.</li> <li> Scientific_Study_Title: Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors.</li> <li> Scientific_Study_Authors: Sudheer et al. (as per PubMed listing; study details available on PubMed abstract page).</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26068424/</li> <li> Scientific_Study_Excerpt: <p>In vitro and animal receptor studies demonstrated that aqueous ashwagandha root extracts activate ionotropic GABAA and GABAρ receptors and exert GABA-mimetic actions; this provides a plausible basis for additive sedation when combined with benzodiazepines or other sedative agents. (Paraphrase.)</p> </li> </ul> <h4> Concurrent use with drugs metabolized by CYP3A4 / CYP1A2 (possible enzyme modulation) [People on many common prescriptions]</h4> <ul> <li> 💊⚖️</li> <li> Recommendation: Consult a clinician or pharmacist before combining ashwagandha with drugs metabolized by CYP3A4 or CYP1A2 (e.g., many statins, calcium channel blockers, immunosuppressants, some benzodiazepines); monitoring or dose adjustment may be needed.</li> <li> Reasoning: In vitro and hepatocyte studies show ashwagandha extracts can induce or modulate PXR/AhR pathways and CYP enzymes; this can lower or raise levels of co-administered drugs depending on direction of effect.</li> <li> Scientific_Study_Title: Evaluation of the Herb-Drug Interaction Potential of Commonly Used Botanicals on the US Market with Regard to PXR- and AhR-Mediated Influences on CYP3A4 and CYP1A2.</li> <li> Scientific_Study_Authors: Mona H Haron, Olivia Dale, Katherine Martin, et al.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/36017806/</li> <li> Scientific_Study_Excerpt: <p>Screening of many botanicals showed W. somnifera extracts activated hPXR and hAhR and produced >50% induction of CYP3A4/CYP1A2 in vitro; authors highlight the potential for clinically relevant herb-drug interactions and recommend in vivo follow-up. (Paraphrase.)</p> </li> </ul> <h4> Cardiovascular instability / on multiple antihypertensives (use caution) [People taking blood pressure meds or with low BP]</h4> <ul> <li> ❤️‍🩹</li> <li> Recommendation: If you take blood-pressure lowering drugs or have orthostatic symptoms, consult your clinician before starting ashwagandha and monitor BP frequently after starting.</li> <li> Reasoning: Some clinical studies and trials report modest reductions in resting blood pressure and heart rate with ashwagandha; additive hypotensive effects are possible with antihypertensive medications.</li> <li> Scientific_Study_Title: Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial (secondary outcomes include pulse and BP changes).</li> <li> Scientific_Study_Authors: (see trial authors in PubMed entry for full author list; study reports cardiovascular/physiologic secondary outcomes).</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/38732539/</li> <li> Scientific_Study_Excerpt: <p>The randomized study found reductions in pulse rate and some stress-related physiological measures in participants taking ashwagandha; while BP changes were not the primary endpoint, the observed autonomic shifts suggest potential additive effects with antihypertensive medications. (Paraphrase.)</p> </li> </ul>